Loading...

Home
ETF
GHRS

GHRS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

GHRS News

GH Research Reports Strong Cash Position Amid Q1 Loss

May 14 2026seekingalpha

GH Research Prices $117.5 Million Stock Offering

Apr 29 2026seekingalpha

Trump Signs Executive Order to Accelerate Psychedelic Research

Apr 20 2026CNBC

Trump Signs Executive Order on Psychedelics, Boosting Compass Pathways Stock

Apr 20 2026Yahoo Finance

Trump Signs Executive Order to Accelerate Psychedelic Drug Reviews

Apr 20 2026Newsfilter

Trump Administration to Examine Safety of Psychedelic Drug for PTSD

Apr 18 2026Yahoo Finance

Trump Administration to Examine Ibogaine Research for PTSD Funding

Apr 16 2026stocktwits

GH001 Shows Promising Results in Treatment-Resistant Depression Study

Mar 25 2026Newsfilter

Helus Pharma Advances New Drug for Anxiety Treatment

Mar 09 2026Newsfilter

Helus Pharma Advances Mental Health Treatments with Promising Phase 2 Results

Mar 09 2026PRnewswire

GH Research Reports FY 2025 Financial Results

Mar 05 2026seekingalpha

Helus Pharma Advances Mental Health Drug Development

Feb 27 2026Newsfilter

Helus Pharma Advances Psychedelic Drug Clinical Trials

Feb 27 2026PRnewswire

US Stocks Close Higher, S&P 500 Hits One-Week High

Jan 06 2026NASDAQ.COM

US Stock Indices Rise with Energy Stocks Leading Gains

Jan 05 2026NASDAQ.COM

Momentus Inc. Shares Surge 57% Following Fuel Tank Development Announcement

Jan 05 2026Benzinga